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Proper maintenance of stem cells is essential for successful utilization of ESCs/iPSCs as tools in developmental and drug discovery
studies and in regenerative medicine. Standardization is critical for all future applications of stem cells and necessary to fully
understand their potential. This study reports a novel approach for the eﬃcient, consistent expansion of human ESCs and iPSCs
usinglasersectioning,insteadofmechanicaldevicesorenzymes,todivideculturesintodeﬁnedsizeclumpsforpropagation.Laser-
mediatedpropagationmaintainedthepluripotency,quality,andgeneticstabilityofESCs/iPSCsandledtoenhanceddiﬀerentiation
potential. This approach removes the variability associated with ESC/iPSC propagation, signiﬁcantly reduces the expertise, labor,
and time associated with manual passaging techniques and provides the basis for scalable delivery of standardized ESC/iPSC lines.
Adoption of standardized protocols would allow researchers to understand the role of genetics, environment, and/or procedural
eﬀects on stem cells and would ensure reproducible production of stem cell cultures for use in clinical/therapeutic applications.
1.Introduction
Human embryonic and induced pluripotent stem cell (ESC,
iPSC) lines have been derived and maintained in a variety
of ways, creating extensive variability and inconsistency from
laboratory to laboratory. Currently, ESC and iPSC lines
are cultured under diverse conditions, involving numerous
methods of expansion, both feeder-dependent and feeder-
independentmatrices,andavarietyofmediumformulations
[1–8]. Large-scale practical utilization of human ESCs and
iPSCs for drug discovery applications, developmental and
disease models, and regenerative therapeutic applications,
will require more consistent and scalable culturing methods.
Likewise, generation of GMP-quality stem cell lines will re-
quire standardized, traceable methods for stem cell deriva-
tion and expansion [9].
Manual passage, using specialized stem cell knives, ra-
zors, or pipettes to physically section stem cell colonies, is
widely accepted as the best method for propagation of
human ESC and iPSC lines. Manual propagation of stem cell
lines does not involve the use of enzymes and therefore is
thought to better maintain genetic stability of human ESCs
and iPSCs in long-term culture [10–14]. Other beneﬁts of
manual expansion of stem cell cultures include passage of
similar sized cell clumps, low cellular trauma, and selective
transfer of speciﬁc undiﬀerentiated colonies [7, 15].
However, scale-up of multiple stem cell lines using these
methodsisunattractivebecauseofthehighlaborcost,incon-
sistency of output associated with varying expertise, risk of
contamination, andtheinability toeﬀectivelyautomate.Due
to these technical demands associated with manual passage,
routine propagation of most human ESC and iPSC lines is
often performed using enzymatic passage [5, 6]. Enzymatic
methods (e.g., using accutase, collagenase, dispase, trypsin,
or TrypLE) are usually used for large-scale expansion and
are well suited for automated platforms [16]. However, these
methods are highly problematic as enzymatic dissociation
results in variable-sized colonies leading to signiﬁcant2 Stem Cells International
inconsistency among cultures [7]. Also, human ESCs/iPSCs
do not survive well as single cells which limit the utility of
enzymatic propagation [17]. While chemical compounds
(e.g., ROCK inhibitor) may be used to promote survival
of dissociated stem cells, these compounds do not alleviate
the heterogeneity associated with enzymatically passaged
human ESC and iPSC cultures, nor is the full impact of
routine usage of such compounds known [18]. The large
heterogeneity in colony size also limits the usefulness of high
density plates, such as 96-well and 384-well plates, for higher
throughput applications.
This study reports a novel approach for the expansion of
human stem cell lines using laser-based propagation. Laser-
mediated passaging was performed by precise cutting of
human stem cell cultures by a laser into speciﬁc sized cell
sections.Thesecellsectionsweretransferredbysimplepipet-
ting to new culture dishes for propagation. The cell sections
were of uniform size leading to greater uniformity of the
resultingcolonies.Additionally,enzyme-freeconditionswere
maintained throughout and all processing occurred within
a sterile, closed environment. Operating within standard
format multiwell plates enable incorporation of automated
robotic systemsforscalabledelivery of standardized stemcell
cultures.
Laser-mediated propagation maintained the quality and
pluripotency of ESC/iPSCs and led to enhanced diﬀerentia-
tion potential. This approach removes the variability associ-
ated with passaging stem cells, which should greatly improve
the evaluation of gene expression signatures, genetic/epi-
genetic proﬁles, and diﬀerentiation capabilities/eﬃciencies
of stem cell lines. Laser-mediated ESC/iPSC passage signiﬁ-
cantly reduces the expertise, labor, and time associated with
manual passaging techniques and provides the basis for re-
producible propagation of GMP-quality human stem cell
lines.
2.MaterialsandMethods
2.1. Human ESC and iPSC Culture. Four human iPSC lines
(BIMR 6, P15–40, and BIMR 14, P25–40 generated from
adult ﬁbroblasts, BIMR A, P20–50 and BIMR L, P30–45
generated from fetal ﬁbroblasts, all transduced with retro-
viruses containing Oct4, Sox2, Klf4,a n dc-Myc genes, Burn-
ham Institute for Medical Research (BIMR)) were cultured
in KODMEM supplemented with 20% KnockOut Serum
Replacement, 1% GlutaMax, 1% nonessential amino acids,
0.1mM 2-mercaptoethanol, and 8ng/mL bFGF (all from
Invitrogen). iPSCs were expanded on PMEF-CFs (Millipore)
or Matrigel (BD Biosciences, in medium conditioned using
PMEF-CFs), medium was changed every day and cells were
passaged at 1:2–1:8 every 5–7 days. H9 human ESCs (P35–
65) were cultured using the same medium on PMEF-CFs
and were passaged 1:2–1:4 every 5–7 days. Experiments
involvingH9humanESCswereperformedattheBIMRStem
Cell Core.
iPSCs were passaged by several methods including man-
ual passage using a pipette tip or using StemPro EZPassage
Disposable Stem Cell Passaging Tool (Invitrogen), enzymatic
passage using collagenase IV (Invitrogen) or 0.05% trypsin
(Invitrogen),andlaser-mediatedpassageusingtheLEAPCell
Processing Workstation (Intrexon Corp).
Stem cell colony size was determined by measuring the
longest diameter of colonies from brightﬁeld images and
by manual counting of Hoechst (Invitrogen) stained nuclei
from ﬂuorescent images. Whole well brightﬁeld images of
stem cell cultures were acquired on LEAP (Intrexon Corp)
and Cel´ ıgo (Brooks Automation, Inc). To generate ESC/iPSC
growth curves, 0.25% trypsin (Invitrogen) was used to pro-
duce a single-cell suspension of ESC/iPSCs which were then
counted using a hemocytometer on days 0–5 after passage.
Transfer eﬃciency after laser-mediated passage was de-
termined by manual counting of the number of ESC/iPSC
sections per well after sectioning (prior to section removal
by pipetting), after removal of sections from the processed
well, and after transfer of sections to new culture plates
using whole well brightﬁeld images. Two days after passage,
passage eﬃciency was determined by manual counting of the
number of alkaline phosphatase positive colonies in cultures
containing transferred sections.
2.2. Laser-Mediated Passage. Optimal laser processing con-
ditions were established assessing laser power, laser spot size,
and density of laser spots for cutting stem cell colonies into
sections with minimal loss of cells. Assessment was per-
formed empirically by testing the ability of a given condition
to consistently cut typical stem cell cultures across 96-,
12-, and 6-well plates. Photothermal laser processing was
chosen to minimize cell loss during processing [19]. Laser
pulse powers from 3–10μJ and laser spot sizes from 10–
25um were systematically evaluated for sectioning through
stem cell cultures of varying thickness. It was determined
that ∼8μJ laser power delivered in a 10um spot size was
suﬃcient to section cultures of all thicknesses. To create a
continuous sectioning line, laser pulses were positioned ∼
16μmapartinalinetoeﬀectivelycutstemcellcolonies.After
processing, samples were washed, sections were dislodged by
pipetting using normal iPSC/ESC medium, and all sections
weretransferredtofreshcultureplatescontainingPMEF-CFs
or Matrigel. Cells were passaged at 1:2–1:8 every 5–7 days.
2.3. Human ESC/iPSC Diﬀerentiation. Embryoid bodies
(EBs) were generated using collagenase IV treatment of day
5 human iPSC cultures for 0.5–1.0 hour to remove colonies
from culture dishes. Colonies were grown in diﬀerentiation
medium in suspension culture using Ultra Low Attachment
plates (Corning). The longest diameter of resulting EBs was
manually measured using brightﬁeld images acquired on
LEAP (Intrexon Corp) on day 4 or 5 of suspension culture.
Human iPSCs were induced to spontaneously diﬀer-
entiate in medium composed of KODMEM supplemented
with20%KnockOutSerumReplacement,1%GlutaMax,1%
nonessential amino acids, and 0.1mM 2-mercaptoethanol
(Invitrogen). EBs were grown in suspension culture for 8
days and then plated onto gelatin-coated plates and allowed
to diﬀerentiate for an additional 8 days. Medium wasStem Cells International 3
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immunocytochemical analyses.
Human iPSCs were induced to form cardiomyocytes by
culturing EBs for 4 days in suspension culture in medium
composed of KODMEM (Invitrogen) supplemented with
20% fetal bovine serum (FBS, Hyclone), 1% Glutamax, 1%
nonessential amino acids, and 0.1nM 2-mercaptoethanol
(Invitrogen). On the 4th day, EBs were plated onto gelatin-
coated plates and allowed to diﬀerentiate for an additional
18 days (22 total days). Medium was changed every other
day. RNA was collected for QRT-PCR analyses on day 16, the
number of contracting EBs was counted on days 16 and 22,
andcultureswereﬁxedforimmunocytochemicalanalyseson
day 22.
Human iPSCs were induced to form neural rosettes by
culturing EBs for 7 days in suspension culture in medium
composed of 50% DMEM/F12, 50% Neurobasal medium
supplemented with glutamax, 0.5x N2 supplement, 0.5x
B27 supplement (Invitrogen), 0.5mM ascorbic acid, 0.1%
albumin, 4.5 × 10
−4 M MTG (Sigma), and bFGF (20ng/mL,
Peprotech). On the 7th day, EBs were plated onto gelatin-
coated plates in the medium described above supplemented
with EGF (20ng/mL, Peprotech) and allowed to diﬀerentiate
for an additional 4 days. On day 11, the number of EBs
containing ≥1 neural rosette was manually counted.
2.4. Immunocytochemistry. Cells were ﬁxed in 4% parafor-
maldehyde in PBS for 15min, permeabilized in 0.1% Triton-
X100 in PBS for 5min, and then blocked for 1 hour in
blocking buﬀer (10% serum of the same species as the
secondary antibody, 0.05% Triton X-100 in PBS). Cells were
washed and incubated with primary antibodies in 1% serum
(same species as the secondary antibody) in PBS for 2 hours
atroomtemperatureorovernightat4◦C.HumaniPSC/ESCs
were characterized using the following antibodies: Oct4,
Sox2, and Nanog (R & D Systems), SSEA4 (Developmental
Studies Hybridoma Bank), and TRA1-60 and TRA1-81
(Santa Cruz Biotechnology). Apoptosis was analyzed using
the following antibodies: caspase-3 and cleaved PARP (BD
Biosciences) with staurosporine treatment of iPSC cultures
used as a control (10μM staurosporine, 4 hour treatment).
Diﬀerentiated iPSCs were characterized using the following
antibodies: Nestin, Map2, ANP (NPPA), and Troponin I
(Millipore), Brachyury and Sox17 (R & D Systems), AFP
and α-actinin (Sigma), and α-MHC (Developmental Studies
Hybridoma Bank). Cells were then washed and incubated
with Alexa Fluor-conjugated secondary antibodies (Invitro-
gen) for 2 hours. All antibodies were diluted according to
manufacturer’s instructions. Cell nuclei were stained with
Hoechst (Invitrogen). All images were acquired using the
LEAP system (Intrexon Corp).
2.5. Alkaline Phosphatase Staining. C e l l sw e r eﬁ x e di n4 %
paraformaldehyde in PBS for 15min and stained with Fast
Red TR hemi (zinc chloride) salt (Sigma) and Naphthol, AS-
MX phosphate alkaline solution (Sigma) in H2O for 15–
30min. All images were acquired using the LEAP system
(Intrexon Corp).
2.6. Quantitative RT-PCR Analysis. RNA was prepared using
the RNeasy Micro/Mini Kit (Qiagen) and cDNA synthesis
was performed using the ABI High Capacity cDNA Reverse
Transcription Kit. QRT-PCR was performed in triplicate for
each primer set and in each cell sample using an ABI
7900HT Sequence Detection System. Ampliﬁcation was per-
formed using the Taqman Univeral PCR Mastermix (ABI).
Speciﬁc primers and probes for stem-cell-associated genes,
diﬀerentiation-associated genes, and cardiomyocyte genes
were obtained from ABI. Stem-cell-associated genes
included Pou5f1 (Hs00999632 g1), Sox2 (Hs01053049 s1),
Nanog (Hs02387400 g1), Tert (Hs99999022 m1), Zfp42
(Hs00399279 m1), Dppa2 (Hs00414515 m1), and Esg1
(Hs00988349 g1). Cardiomyocte-associated genes includ-
ed Nkx2.5 (Hs00231763 m1), TnnI3 (Hs00165957 m1),
Actn1 (Hs00998100 m1), Mef2C (Hs01554599 m1), Myh6
(Hs00411908 m1), and Nppa (Hs00383230 g1). Expression
levels of all genes were normalized to Eukaryotic 18s rRNA
(Hs99999901 s1), and then analyzed using the 2ΔΔCt method
[20].
2.7. Karyotype Analysis. Live cell cultures were analyzed by
Cell Line Genetics. Cytogenetic analysis was performed on
twenty G-banded metaphase cells.
2.8. aCGH Analysis. Genomic DNA was collected and puri-
ﬁed using the Gentra Puregene Cell Kit (Qiagen). Hybridiza-
tionwasconductedwiththe44KHumanStemArray(Ambry
Genetics), with a resolution of ∼24kb over the entire
genome and high resolution exonic coverage in known stem-
cell-associated genes, tumor suppressors, and oncogenes.
Samples were hybridized to a sex-matched pooled normal
reference DNA (Promega). Data was analyzed by Ambry
Genetics using DNA Analytics (Agilent) and reported using
genome build HG18.
2.9. Statistical Analysis. Statistical analyses were performed
using GraphPad Prism with a P value of ≤0.05 considered
to be signiﬁcant. One way analysis of variance (ANOVA)
with Bartlett’s test for equal variances was performed to
evaluate resulting colony sizes generated after passage by ﬁve
techniques (n = 20 colonies/sample, Figure 2(c)) and result-
ing EB sizes generated from laser-mediated, collagenase, and
trypsin-passaged cells (n = 30 EB/sample, Figure 5(b)).
Statistical analysis of QRT-PCR data (n = 3, Figures 4(c) and
5(d)) was performed using a two-tailed t-test.
3. Results
3.1. Optimization of Laser-Mediated Passage. Laser-mediated
passagingconditionswereoptimizedusingfourhumaniPSC
lines and one human ESC line. Human iPSC/ESC cultures
were initially passaged by standard methodology (i.e., col-
lagenase treatment plus manual scraping of cultures) into
plates containing mitomycin c-treated murine embryonic
ﬁbroblasts and cultured for 5 days in iPSC/ESC medium.
Laser-mediated cutting of stem cell colonies into clumps or
sections of cells was facilitated by addition of a reagent to4 Stem Cells International
increase photothermal absorption of the laser’s energy by
the culture medium [19]. Laser processing conditions were
optimized with respect to laser power, laser spot size, and
numberoflasershotsrequiredtoeﬀectivelycutcultureswith
minimal loss of cells.
To determine the impact of section size on resulting
colony size, stem cell cultures were cut into square cell
sections ranging from 75 to 300μm in size and transferred
to new culture dishes by gentle pipetting (Figure 1(a),
hiPSCs (top, middle), hESCs (bottom)). Sections below
75μm contained very few cells (<8 cells/section), whereas
300μm sections were too large to easily remove from the
plate by gentle pipetting alone. Stem cell colony size and
number of cells per colony were assessed by brightﬁeld
imaging and ﬂuorescent staining of nuclei, respectively, after
processing cultures into 100–250μm sections (Figure 1(b)).
Human iPSC cultures sectioned into 100, 150, 200, and
250μmsizesresultedinsectionscontaining12,25,47,and68
cells, respectively (Figure 1(b),t o p ) .T h r e ed a y sa f t e rp a s s a g e
human iPSC colonies measured 306, 367, 493, and 693μm
in diameter with 62, 119, 184, and 283 cells per colony,
respectively. Similar results were obtained with all iPSC cell
lines (data not shown) and with human ESCs (Figure 1(b),
bottom) using the same laser processing conditions.
For routine propagation of iPSC and ESC cultures,
section sizes of 200μm were used, which allowed consistent
splitting every 7 days. Notably, other groups have identiﬁed
200μm (50–100 cells) as the optimal clump size for passage
[1,5,15,21].PropagationofhumaniPSCsusing200μmsec-
tions was highly eﬃcient with an average transfer eﬃciency
of 91 ± 2% with 93 ± 5% of the transferred sections forming
viable colonies for an overall passage eﬃciency of 85 ± 3%.
Passage of human ESCs resulted in similar data (overall
passageeﬃciencyof ∼82%,datanotshown).Laser-mediated
passage with the current system required a total of ∼50–
90min to process an entire plate of stem cells (depending
on plate type using 200μm sections; with the majority of
time (>90%) spent for laser processing and only a few
minutes spent by the user). iPSCs and ESCs cultured under
feeder-free conditions were also successfully propagated
usingthesamelaser-mediatedpassageconditions.Thesedata
demonstrate that multiple stem cell lines can be propagated
by laser-based passage and that the size of resulting colonies
can be easily controlled by varying the input section size.
3.2. Improved Consistency of Stem Cell Cultures. Laser-
mediated passage was compared with traditional passaging
techniques, both manual and enzymatic. iPSC cultures
(BIMR 6) were passaged by (1) laser-mediated passage using
200μm sections, (2) manual passage using the StemPro
EZPassage Disposable Stem Cell Passaging Tool (Invitrogen),
(3) manual passage using a pipette tip (performed by an
individual with 6-years experience), (4) enzymatic passage
using collagenase, and (5) enzymatic passage using trypsin.
Manual passage approaches generated signiﬁcantly more
uniform colonies than the enzymatic methods. Compar-
ing laser-mediated passage with collagenase-based passage,
image analysis of laser-passaged cultures revealed more
homogeneous colony formation than collagenase passaged
cultures (Figures 2(a) and 2(b).S t e mc e l lc u l t u r e sp a s s a g e d
byallmethodswereanalyzedwithrespecttocolonydiameter
and cells per colony (Figure 2(c)). Laser-mediated passage
resulted in the most uniform colonies measuring 240 ±
43μm (18% CV) in diameter containing 45 ± 7 (16% CV)
cells per colony one day after passage. Enzymatic passage
by collagenase or trypsin resulted in signiﬁcantly variable
sized colonies measuring 365 ± 177μm(48% CV) and 172 ±
97μm (56% CV) in diameter containing 90 ± 42 (47% CV)
and 25 ± 19 (76% CV) cells per colony, respectively. Manual
passage techniques using a pipette tip or the EZPassage tool
resulted in more similar sized colonies measuring 214 ±
9μm (37% CV) with 34 ± 3 (37% CV) cells per colony and
226 ±65μm (29% CV) in diameter with 37 ± 9 (25% CV)
cells per colony, respectively. However, the EZPassage tool
does not allow colonies growing at the edge of each well
to be propagated, leaving >25% of the culture unsectioned
(data not shown). Statistical analysis of variance showed that
the stem cell cultures propagated by laser-mediated passage
varied signiﬁcantly less than (P value < 0.0001) cultures
passaged manually or by enzymatic methods, demonstrating
that laser-mediated passage results in more consistent stem
cellculturesthanallothermethods.Comparableresultswere
also obtained using the BIMR A iPSC line (data not shown).
3.3. Pluripotency, Quality, and Stability of Stem Cells after
Laser-Mediated Passage. The eﬀect of the laser on human
iPSC and ESC quality and pluripotency was examined
immediately following laser-mediated sectioning of stem cell
cultures into 200μm sections. As shown in Figure 3(a),
pluripotency markers such as Oct4, Sox2, Nanog, SSEA4,
TRA1-60, and TRA1-81 were highly expressed in sectioned
iPSC cultures. Image analysis demonstrated that all markers
were expressed homogeneously across sections, even in cells
right next to the laser sectioning lines. In addition, cells right
next to the laser cutting lines did not show any signiﬁcant
increase in apoptosis, as measured by immunocytochemical
analysis of activated caspase-3 and cleaved PARP four hours
after laser-mediated sectioning (Figure 3(b)). Incubation of
replicate cultures overnight (i.e., cultures were sectioned
into 200μm sizes and then given fresh medium) resulted in
signiﬁcant growth of cells into the areas previously sectioned
using the laser. Morphological and immunocytochemical
analysis of these cultures (using the same pluripotency and
apoptosis markers above) indicated that cells regrown into
thelasersectioningareawereindeedundiﬀerentiatedhuman
iPSCs. The laser was then used to section a wider area (∼
1000μm) into cultures for analysis of growth over several
days.Again,theseculturesshowednochangeinmorphology,
apoptosis, and pluripotency marker expression, indicating
that laser processing did not aﬀect stem cell self-renewal or
pluripotency (Supplemental Figure 1 of the supplementary
material available online at doi:10.1155/2012/926463).
In addition, laser-mediated passage of human iPSCs and
ESCsdidnotaltercellgrowthasthecellsexhibitedequivalent
growth rates as compared with collagenase passaged cells
after multiple rounds of expansion (Figure 3(c)).Stem Cells International 5
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Figure 1: Stem cell colony size was controlled by section size using laser-mediated passage. (a) Brightﬁeld images of human iPSC (top,
middle) and ESC (bottom) cultures cut into 100–250μm sections. Scale bar, 1mm. (b) Colony size over time following propagation of 100–
250μm iPSC sections (top) or ESC sections (bottom) by laser-mediated passage. Number of cells per colony were manually counted using
Hoechst stained cultures (left, n = 15 colonies per data point). Longest diameter of each colony was manually measured using brightﬁeld
images (right, n = 15 colonies per data point). Data are shown as mean + s.d.
To further assess the potential laser eﬀects on human
iPSC and ESC stability and pluripotency, stem cell cultures
were propagated using laser-mediated passage over long-
termculture(twoiPSClinesweremaintainedfor>5passages
(5 weeks), one iPSC line was maintained for >10 passages
(2.5 months), and BIMR 6 iPSCs and H9 ESCs were
maintained for >24 passages (>6 months)) and compared
with replicate cultures passaged using collagenase. Image6 Stem Cells International
Laser Collagenase
(a)
Laser Collagenase
(b)
1200
1000
800
600
400
200
0
L
a
s
e
r
E
Z
 
p
a
s
s
a
g
e
M
a
n
u
a
l
C
o
l
l
a
g
e
n
a
s
e
T
r
y
p
s
i
n
Passage method
C
o
l
o
n
y
 
d
i
a
m
e
t
e
r
 
(
μ
m
)
-
d
a
y
 
1
18 29
37
48
56
∗
∗
∗
∗
1200
1000
800
600
400
200
0
L
a
s
e
r
E
Z
 
p
a
s
s
a
g
e
M
a
n
u
a
l
C
o
l
l
a
g
e
n
a
s
e
T
r
y
p
s
i
n
Passage method
C
o
l
o
n
y
 
d
i
a
m
e
t
e
r
 
(
μ
m
)
-
d
a
y
 
3
L
a
s
e
r
E
Z
 
p
a
s
s
a
g
e
M
a
n
u
a
l
C
o
l
l
a
g
e
n
a
s
e
T
r
y
p
s
i
n
Passage method
L
a
s
e
r
E
Z
 
p
a
s
s
a
g
e
M
a
n
u
a
l
C
o
l
l
a
g
e
n
a
s
e
T
r
y
p
s
i
n
Passage method
C
e
l
l
s
/
c
o
l
o
n
y
 
(
#
)
-
d
a
y
 
1 600
500
400
300
200
100
0
C
e
l
l
s
/
c
o
l
o
n
y
 
(
#
)
-
d
a
y
 
3 600
500
400
300
200
100
0
150
100
50
0
L
a
s
e
r
E
Z
 
p
a
s
s
a
g
e
M
a
n
u
a
l
C
o
l
l
a
g
e
n
a
s
e
T
r
y
p
s
i
n
17
29
35
42
52
∗
∗
∗
∗
16 25 37
47
76
∗ ∗
∗
∗
14
29
38
49
68
∗
∗
∗
∗
(c)
Figure 2: Improved uniformity of stem cell cultures by laser-mediated passage. (a) Brightﬁeld images of iPSC cultures 2 days after laser-
mediated passage (200μm sections, left) or collagenase passage (right). Colonies are shown by red outline. Scale bar, 1mm. (b) Alkaline
phosphatase (AP) staining of iPSC colonies 1 day after laser-mediated passage (200μm sections, left) or collagenase passage (right). Scale
bar, 1mm. (c) Colony size of iPSC cultures on days 1 and 3 after laser-mediated passage (200μm sections), StemPro EZPassage Disposable
Stem Cell Passaging Tool (EZ Passage), manual passage using a pipette tip, collagenase treatment, or trypsin dissociation of cells. Longest
diameter of each colony was manually measured using brightﬁeld images (top, n = 20 colonies per data point). Number of cells per colony
was manually counted using Hoechst stained cultures (bottom, n = 15 colonies per data point). Data are shown as scatter plot with red
line indicating mean. The CV is shown in red text above each sample. Asterisks (∗) indicate variances that are statistically signiﬁcant when
compared to laser-mediated passage using ANOVA, with a P ≤ 0.05 considered signiﬁcant.
analyses of cultures propagated by laser-mediated passage
showed no change in morphology with all cells exhibiting
a high nuclear to cytoplasmic ratio typical of pluripotent
stem cells (Figure 4(a)). Immunocytochemical analyses of
these cultures demonstrated iPSCs and ESCs continued to
express characteristic pluripotency markers including alka-
line phosphatase (AP), Oct4, Sox2, Nanog, SSEA4, TRA1-60,
and TRA1-81 (Figure 4(a)).
VisualcomparisonshowedthathumanBIMR6iPSCcul-
turespropagatedusinglaser-mediatedpassagewereofhigher
quality over time than those propagated using collagenase.
Cultures propagated by laser-mediated passage contained
many more undiﬀerentiated, compact stem cell colonies
with clear discernible colony borders compared to cultures
propagated using collagenase. Collagenase passaged cultures
had a greater tendency for spontaneous diﬀerentiationStem Cells International 7
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Figure 3: Quality of iPSC cultures after laser-mediated passage. (a) Immunocytochemical analysis of Oct4, Sox2, Nanog, SSEA4, TRA1-60,
andTRA1-81expressionimmediatelyfollowinglaser-mediatedsectioningofiPSCcultures(BIMRL)into200μmsections.Hoechstwasused
asanuclearcounterstain.NotethatallmarkersareexpressedhomogeneouslyacrossiPSCclumps.Scalebar,1mm.(b)Immunocytochemical
analysis of apoptosis markers, caspase-3, and cleaved PARP, following laser-mediated sectioning of iPSC cultures. Hoechst was used as a
nuclear counterstain. Scale bar, 1mm. (c) Analysis of iPSC (BIMR 6, left) and ESC (H9, right) growth following propagation using laser-
mediated passage or collagenase passage. P indicates passage number. Data are shown as mean + s.d. (n = 3).8 Stem Cells International
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Figure 4: Pluripotency and stability of stem cells after laser-mediated passage. (a) Colony morphology (brightﬁeld, BF) and
immunocytochemical analysis of Oct4, Sox2, Nanog, alkaline phosphatase (AP), SSEA4, TRA1-60, and TRA1-81 expression in human ESCs
(H9) after 24 consecutive laser-mediated passages. Hoechst was used as a nuclear counterstain. Scale bar, 250μm. (b) Whole well brightﬁeld
images of human iPSC (BIMR 6) cultures after 10 consecutive laser-mediated passages or collagenase passages. Scale bar, 5mm. (c) QRT-
PCRanalysis of stem-cell-associated gene expression in iPSCs(BIMR6) after 10 consecutive laser-mediated passages or collagenase passages.
The asterisks (∗) indicate values that are statistically signiﬁcant compared with the starting population of iPSCs. The data are presented as
mean ± s.d. (n = 3). Statistical analysis was performed using t-test, with a P value ≤ 0.05 considered to be signiﬁcant. (d) Normal karyotype
of H9 human ESCs after 24 laser-mediated passages (6 months). (e) Schematic depicting genomic abnormalities of H9 ESCs at P35 (starting
population) and at P59, after 24 laser-mediated passages (6 months), as determined by aCGH. No new subkaryotypic abnormalities were
detected after 24 passages. Red bars indicate a deletion. Green bars indicate an ampliﬁcation. See Table 1 for complete list of aberrations
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(Figure 4(b)). To quantify these phenotypic observations,
QRT-PCR analyses were performed using known markers
for undiﬀerentiated stem cells. As shown in Figure 4(c),
iPSCs propagated using laser-mediated passage continued to
express high levels of stem cell-associated genes, including
Oct4 (Pou5f1), Sox2, Nanog, Tert, Zfp42 (Rex1), Dppa2,
and Esg1 (Dppa5), similar to the starting population of
iPSCs (no statistical diﬀerence, P value ≥ 0.1). In contrast,
iPSCs propagated using collagenase resulted in a signiﬁcant
decrease in expression of Sox2, Nanog, Tert, Zfp42,a n dEsg1
when compared to the starting population of iPSCs (P value
< 0.05, Figure 4(c)). Comparison of human ESC cultures
passaged by both methods did not show any signiﬁcant
morphological changes or diﬀerences in gene expression
(SupplementalFigure2),althoughhumanESCcultureswere
more established, later passage cultures than human iPSC
cultures used in these experiments.
Data from multiple groups have shown that H9 human
ESCs maintain a stable karyotype over long-term culture
[1, 17, 22]. These cells were therefore used to examine the
genetic stability of stem cells after long-term propagation
using laser-mediated passage. Karyotype analysis of H9 ESCs
after 24 consecutive laser-mediated passages showed no
change in karyotype with all cells having a normal diploid
karyotype (6 months, Figure 4(d)). To detect subkary-
otypic alterations, array comparative genomic hybridiza-
tion (aCGH) was also performed using the Stemarray
(Figure 4(e),T a b l e1). No subkaryotypic alterations were
detected in human ESCs propagated for 24 consecutive
passages (P59) by laser-based passaging relative to the
starting population (H9, P35), suggesting that the genome
of laser-mediated passaged cells is both normal and stable. It
is important to note that both subkaryotypic and karyotypic
alterations were observed in H9 ESCs after consecutive
passaging by collagenase for 4 and 6 months, respectively
(data not shown). In addition, no subkaryotypic changes
were detected in human iPSCs (BIMR 6) propagated for
10 consecutive passages by laser-mediated passage relative
to the starting population (data not shown). Although
genetic stability of iPSCs was only analyzed after 2.5 months,
taken together with 6-month human ESC results, these data
suggest that the genome of laser-mediated passaged stem
cells is and stable.
3.4. Improved Diﬀerentiation Potential of EBs Generated after
Laser-Mediated Passage. To test the diﬀerentiation potential
of these cells, in vitro diﬀerentiation assays of human iPSCs
were performed after propagation using laser-mediated
passage (160μm sections) or enzymatic passage. iPSCs
passaged by either methodology eﬃciently formed well-
deﬁned embryoid bodies in suspension culture which could
diﬀerentiate into derivatives of all three primary germ layers
including endodermal cells (Sox17, Afp), mesodermal cells/
cardiac muscle cells (brachyury, α-MHC), and ectodermal
cells/neurons (Nestin, Map2, Supplemental Figure 3). Mor-
phological analysis of the resulting EB populations showed
that EBs generated from laser-passaged iPSCs were more
uniform in size than those generated from enzymatically
passagediPSCs(Figure5(a)).Toquantifytheseobservations,
the diameter of resulting EB populations was measured
manually using images acquired on day 4 of suspension
culture. As shown in Figure 5(b), laser-mediated passage
resulted in signiﬁcantly more uniform EBs (374± 56μm;
15% CV) than enzymatic passage by either collagenase (336
± 145μm; 43% CV) or trypsin (158 ± 85μm; 54% CV).
Statistical analysis of variance showed that EBs generated
using stem cell cultures propagated by laser-mediated pas-
sage were signiﬁcantly more uniform (P value < 0.0001)
than EBs generated using enzymatically passaged cultures,
demonstrating that laser-mediated passage results in more
consistent EB cultures than other methods.
Several studies have shown that heterogeneity in human
ESC colony size and resulting EB aggregate size results
in variability in diﬀerentiation experiments and signiﬁcant
decreases in diﬀerentiation yields [23–26]. The eﬀect of EB
homogeneity on diﬀerentiation potential of human iPSCs
into cardiomyocytes was examined. EBs were generated
using iPSC colonies formed 5 days after laser-mediated pas-
sage (160μm sections) or enzymatic passage. All EBs were
diﬀerentiated using a standard multistage protocol, growing
EBsinsuspensionculturefor4daysfollowedbyadherentcell
culture for an additional 18 days [27]. Cardiomyocyte diﬀer-
entiation potential was analyzed on day 22 of diﬀerentiation
by manual counting of contracting EBs. EBs produced using
enzymatically passaged iPSCs yielded a small proportion
of beating EBs (∼7%), whereas laser-mediated passaged
iPSCs resulted in a signiﬁcantly higher proportion (∼60%)
of contracting EBs (Figure 5(c)). QRT-PCR analyses con-
ﬁrmed these results with EBs generated from laser-mediated
passaged cultures showing 3- to 51-fold higher expression
of cardiomyocyte genes, Nkx2.5, Actn1 (α-actinin), Mef2C,
Myh6 (α-Mhc), TnnI3,a n dNppA (Anp), than EBs gen-
erated from collagenase passaged cultures (Figure 5(d)).
Similarly, immunocytochemical analyses demonstrated that
EBsproducedfromlaser-mediatedpassagediPSCscontained
substantiallymorecardiaccellswithineachEB(i.e.,EBscon-
tained more cells staining positive for known cardiomyocyte
markers) than EBs produced from collagenase passaged cells
(α-MHC and α-actinin shown in Figure 5(e)). EBs generated
from all populations stained positive for all markers tested
including α-MHC, α-actinin, cardiac troponin, and NPPA
(data not shown).
To further analyze the eﬀect of EB homogeneity on
diﬀerentiation potential, EBs generated from iPSC colonies
formed5daysafterlaser-mediatedpassage(160μmsections)
or enzymatic passage were diﬀerentiated into neural rosettes
using a modiﬁed multistep protocol. Ability to diﬀerentiate
into neural rosettes was analyzed on day 11 of diﬀerentiation
bymanualcountingofEBscontaining ≥1ne uralr osett e.EBs
produced using laser-mediated passaged iPSCs resulted in
95% of EBs containing neural rosettes, while EBs generated
by trypsin or collagenase passaged iPSCs yielded only 29%
and 32% of EBs containing neural rosettes, respectively (data
not shown). These data indicate increased homogeneity in
human iPSC colonies and resultant EBs result in signiﬁcant
increases in diﬀerentiation yield of iPSCs.
To investigate the eﬀect of EB size on diﬀerentia-
tion potential of human iPSCs were examined. iPSCs were10 Stem Cells International
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Figure 5: iPSCs propagated by laser-mediated passage diﬀerentiated more eﬃciently into cardiomyocytes. (a) Brightﬁeld image of day 4
EBs generated from iPSC cultures (BIMR A) propagated by laser-mediated passage, trypsin dissociation, or collagenase treatment. Scale bar,
250μm. (b) Size of EBs generated from iPSC cultures propagated by laser-mediated passage, trypsin dissociation, or collagenase treatment
(n = 35 EBs per data point). Data are shown as scatter plot with red line indicating mean and CV shown in red text above each sample. The
asterisks (∗) indicate variances that are statistically signiﬁcant when compared to laser using ANOVA, with P ≤ 0.05 considered signiﬁcant.
(c)PercentageofEBscontainingcontractingareas.Dataareshownasmean+s.d.(n = 2independentexperimentscontaining75EBs/sample
in each experiment). (d) QRT-PCR analysis of cardiomyocyte-associated gene expression in EBs generated using iPSC cultures propagated
by laser-mediated passage, trypsin dissociation, or collagenase treatment. The asterisks (∗) indicate values that are statistically signiﬁcant as
compared with EBs generated from collagenase passaged iPSC cultures. The data are presented as mean ± s.d. (n = 3). Statistical analysis
was performed using t-test with P ≤ 0.05 considered signiﬁcant. (e) Expression of cardiomyocyte markers, α-MHC and α-actinin, in EBs
generated from iPSC cultures propagated by laser-mediated passage or collagenase treatment on day 22 of cardiac diﬀerentiation. Hoechst
was used as a nuclear counterstain. Scale bars, 250μm.Stem Cells International 11
Table 1: Regions in H9 human ESCs with genomic abberations as determined by aCGH (corresponding schematic is shown in Figure 4(e)).
No subkaryotypic alterations were detected in hESCs propagated for 24 consecutive passages (H9 P59) relative to the starting hESC
population (H9 P35), suggesting that the genome of laser-mediated passaged cells is both normal and stable. Data is reported using genome
built HG18. log2 ratios ≥ 0.6 are ampliﬁcations (amp) or ≤− 1.0 are deletions (del) found in all cells. log2 ratios < 0.6 or > −1.0 represent
mosaicism within the culture.
Chromosome: region Cytoband Size
(Mb) #P r o b e s A m p / D e l H9 P35
log2 ratio
H9 P59
log2 ratio Annotations
Chr1: 224141493-224195678 q42.12 0.054 14 Amp 0.528 0.632 LEFTY1, PYCR2, LEFTY2
Chr6: 31663619-31691605 p21.33 0.028 3 Amp 0.686 1.220 LST1, NCR3, AIF1
Chr12: 21580165-22105263 q12.1 0.282 12 Del −0.495 −0.480 GYS2, LDHB, KCNJ8, ABCC9, CMAS
Chr14: 62486603-62852257 q23.2 0.366 7 Amp 0.560 0.432 KCNH5, RHOJ, GPHB5
Chr17: 35097815-35153082 q12 0.055 15 Amp 0.469 0.485 PERLD1, ERBB2, C17orf37, GRB7
propagatedbylaser-mediatedpassageatvaryingsectionsizes
(80, 160, and 240μm sections). Five days after passage,
EBs were generated and diﬀerentiated into cardiomyocytes
as described above. Homogeneous EB populations (≤15%
CVs)ofvaryingsizes,278,418,and528μmindiameter,were
producedfrom80,160,and240μmsectionsizes,respectively
(Supplemental Figure 4). Analysis of cardiomyocyte diﬀer-
entiation potential showed that 55% of EBs generated from
160μm sections were contracting, while only 38% and 21%
of EBs generated from 240μma n d8 0μm sections were con-
tracting. Taken together, these data indicate that increased
homogeneity in human iPSC colonies and resultant EBs,
as well as EB size, signiﬁcantly increase the diﬀerentiation
yield of iPSCs. The ability to reproducibly generate uniform,
size-speciﬁc colonies which subsequently result in more
uniform, size-speciﬁc EB populations decreases variability
in diﬀerentiation experiments and enhances diﬀerentiation
yields of both ESC and iPSCs into specialized cell types.
4. Discussion
The lack of standardization in passage techniques for stem
cell derivation and propagation is a major limitation within
the stem cell ﬁeld. Because universal protocols for human
stem cell cultures have not been adopted, it is currently
diﬃcult to compare and interpret scientiﬁc data from cells
cultured in diﬀerent conditions. Passage method diﬀerences
have signiﬁcantly confounded the understanding of intra-
and interline diﬀerences in gene expression data, expression
of stem cell- and lineage-associated markers, miRNA sig-
natures, and epigenetic proﬁles [28–31]. Although human
ESC lines have distinct genotypes, it is unlikely that reported
diﬀe r e n c e si nc e l ll i n e s( e . g . ,u pt o6 5 %v a r i a t i o ni ng e n e
expression data across two ESC lines) can be attributed to
genetic variation alone, as <2% variation in gene expression
has been found in adult human tissues of diﬀerent individu-
als[28,32,33].Likewise,discrepanciesassociatedwithdiﬀer-
entiation protocols and reported diﬀerentiation capabilities
and eﬃciencies of stem cells into specialized cell types may
be due to the lack of standardization [34]. Adoption of stan-
dardized protocols should greatly improve determination of
the role of inherent genetic variation, environmental niche,
and/or procedural eﬀects on stem cell quality, self-renewal,
pluripotency, and diﬀerentiation potential.
Laser-mediated passage provides a novel method for
expansion of human ESCs/iPSCs which can be used to
create standardized, traceable procedures for the produc-
tion of GMP-quality stem cell lines without requirement
for enzymes. This method combines the beneﬁts of both
manualandenzymaticpassagetechniques,allowingeﬃcient,
automated passaging of undiﬀerentiated stem cell cultures
into uniform-sized stem cell sections within a sterile closed
environment. Laser-mediated passage is compatible with a
variety of culture methods including animal-free, feeder-
free-based conditions, and serum-free deﬁned media con-
ditions. Notably, this approach is not susceptible to inter-
individual variation reducing the need for skilled technicians
to create high-quality stem cell cultures.
Laser-mediated passage does not involve the use of en-
zymes and therefore should better maintain the genetic
stability of human ESCs and iPSCs in long-term culture
(3–12 months, [10–14]). The results show that H9 ESCs
maintained a stable karyotype over six months (>24 pas-
sages). More importantly, laser-mediated passage did not
induce subkaryotypic alterations over time in H9 ESCs (6
months, and iPSCs (2.5 months)) as monitored by aCGH.
The more sensitive aCGH data suggests that laser-mediated
passage maintains genetic integrity of human ESCs/iPSCs.
Importantly, genetic abnormalities weredetected in H9 ESCs
after consecutive passaging by collagenase during the same
time period. Results also showed that human iPSCs and
ESCs propagated using laser-mediated passage maintained a
normal stem cell morphology and continued to express high
levels of stem-cell-associated genes and proteins. Although
teratoma analyses were not performed on these cells, in vitro
diﬀerentiation analyses of laser-mediated passaged iPSCs
demonstrated the cells could spontaneously diﬀerentiate
into derivatives of all three primary germ layers and could
diﬀerentiate into cardiomyocytes and neural rosettes. In
addition, iPSCs propagated by laser-mediated passage have
beendiﬀerentiatedintomotorneurons,RPEcells,endoderm
progenitors, and hepatocytes-like cells (data not shown);
taken together these data indicate that laser-mediated pas-
sage does not aﬀect stem cell pluripotency. Likewise, laser-
mediated passage did not alter the growth rate of stem cells
or increase expression of apoptotic markers, all supporting
that the laser sectioning did not aﬀect stem cell quality, self-
renewal, or pluripotency.12 Stem Cells International
Laser-mediated passage provides control of stem cell
colony size. Regular passage schedules can be established by
selection of section size. A section size of ∼200μm has ena-
bled routine splitting of all ESC/iPSC lines every 7 days,
allowingformoreeﬃcientplanningofexperiments.Anover-
all passage eﬃciency of 85% combined with more uniform
section sizes (20% CV), enables a larger proportion of ESC/
iPSC colonies to contribute to culture expansion reducing
thenumberofplatesrequiredforculturemaintenance.Com-
patibility with conventional robotic systems enables scalabil-
ity of culture needs. Additionally, the ability to control input
section size, particularly smaller sizes, allows more eﬀective
creation of stem cell colonies in multi-well plates for large-
scaleexperimentationandscreeningpurposes.Itisalsolikely
that stem cell section size will aﬀect cryopreservation and
genetic modiﬁcation eﬃciency of ESCs and iPSCs [35–38].
Laser-mediated passage involves sectioning the entire
well systematically without respect for the boundaries of the
colonies. Well-established undiﬀerentiated stem cell cultures
are easily propagated using this technique. For newly derived
ESC/iPSC cultures, early passage ESC/iPSC lines, or less
stable lines, which tend to have more spontaneous diﬀerenti-
ation,acombinationofmanualselectionorlaserpuriﬁcation
of colonies followed by laser-mediated passage would be
recommended. One of the more important results of this
approachshowedthatovertime,stemcellcultures(inpartic-
ular, early passage iPSCs which tend to be more susceptible
to diﬀerentiation than later passage, more established ESCs)
are of higher quality than those maintained by collagenase
treatment. It is likely that passage of homogeneous sections
is important for maintaining undiﬀerentiated stem cells and
limitingthediﬀerentiationofcolonies.Therefore,potentially
early passage ESCs/iPSCs will require less colony isolation
before expansion using laser-mediated passage.
One of the more important outcomes of this study
showed that uniform human iPSC colonies produced after
laser-mediated passage resulted in a more homogeneous
population of EBs, with respect to size and shape, with
greater diﬀerentiation eﬃciency as compared with typical
EB cultures derived from enzyme passaged cultures. EBs
generated from laser-mediated passaged iPSCs resulted in
a signiﬁcant increase in cardiomyocyte yield, with up to
8.5-fold greater beating incidence than EBs generated from
collagenase passaged iPSCs. The ability to reproducibly
generate uniform colonies using laser-mediated passage
resulting in EBs that are more uniform in size and shape
will decrease variability in diﬀerentiation experiments and
enhance diﬀerentiation yields of both ESC and iPSCs into
specialized cell types. These yield enhancements could
signiﬁcantly reduce the cost of stem cell experimentation
both in terms of labor and materials. Potentially, uniform
colony formation will also augment diﬀerentiation yields of
stem cells when performing direct diﬀerentiation procedures
(i.e., without an EB intermediate).
5. Conclusions
In conclusion, proper maintenance of human stem cells
is essential for successful utilization of ESCs and iPSCs
as tools in developmental and drug discovery studies and
in regenerative medicine. Standardization is critical for all
future applications of stem cells and necessary in order to
fully understand the potential of these cells and the diﬀer-
ences observed among varying stem cell lines and between
ESCs and iPSCs. Laser-mediated passage is an innovative
method for maintenance and expansion of stem cell lines,
without introducing genetic instability, which is generically
applicable to all cell lines and to all technicians regardless
of skill. This approach provides an eﬃcient, standardized
protocol for the propagation of human ESCs and iPSCs,
which should signiﬁcantly reduce the inconsistency and
variability within the stem cell ﬁeld. Laser-mediated passage
allows for traceability and ensures reproducible production
ofstemcelllinesaccordingtostandardoperatingprocedures,
all of which are necessary to manufacture stem cells for use
in clinical/therapeutic applications.
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